|
|
|
|
| Top Story |
 |
|
Pharm Exec’s 2018 Industry Forecast |
In our annual temperature check on the life sciences sector and its outlook for the months ahead, we explore eight trends that will shape the biopharma industry landscape in 2018
... /Read more/ |
|
|
|
| Calendar |
|
/ January 23–24: 13th Biosimilars Summit / |
|
Alexandria, VA |
|
/ January 24–25: Reimbursement and Contracting / |
|
Philadelphia, PA |
|
/ February 7–8, 2018: Speaker Programs 2018 / |
|
Philadelphia, PA |
|
/ March 25–28, 2018: 14th Annual Pharma Forum / |
|
Philadelphia, PA |
|
/ April 10–12, 2018: LogiPharma 2018 / |
|
Montreux, Switzerland |
|
/ May 10–11, 2018: Pharma Marketing Summit / |
|
Palm Beach, FL |
|
/ October 15-17, 2018: 28th Annual Sharing Conference: Compliance / |
|
National Harbor, MD |
|
|
|
| Industry update |
| //sterna biologicals (Marburg, Germany) appointed Christian M. Pangratz as Chief Executive Officer. //Shire (Dublin, Ireland) appointed Thomas Dittrich as Chief Financial Officer and member of the Board of Directors. //Perrigo (Dublin, Ireland) named Uwe Röhrhoff as Chief Executive Officer, effective January 15, following the retirement of John T. Hendrickson. //Merz Pharma Group (Frankfurt, Germany and Raleigh, NC) named Terri L. Phillips, M.D., F.A.A.P., as Vice President and Head of Global Medical Affairs, effective January 2, 2018. Dr. Phillips will be located in the Merz North America headquarters.//
|
|
|
|
